Kaiming Xu

813 total citations
22 papers, 589 citations indexed

About

Kaiming Xu is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Kaiming Xu has authored 22 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Pharmacology and 6 papers in Oncology. Recurrent topics in Kaiming Xu's work include Inflammatory mediators and NSAID effects (6 papers), Receptor Mechanisms and Signaling (4 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Kaiming Xu is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Receptor Mechanisms and Signaling (4 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Kaiming Xu collaborates with scholars based in United States, China and Hong Kong. Kaiming Xu's co-authors include Hui‐Kuo G. Shu, Thomas J. Murphy, T J Murphy, Lanfang Wang, Huiying Gao, Chide Han, Xiaofei Wang, Valerie Boss, Youyi Zhang and Younghyoun Yoon and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Kaiming Xu

21 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaiming Xu United States 14 309 124 113 97 85 22 589
Maureen A. Nickols United States 9 284 0.9× 201 1.6× 76 0.7× 58 0.6× 49 0.6× 10 572
Tak Yung Man United Kingdom 13 342 1.1× 128 1.0× 45 0.4× 80 0.8× 106 1.2× 22 1.2k
Nagadhara Dronadula United States 16 358 1.2× 116 0.9× 51 0.5× 121 1.2× 156 1.8× 22 643
Alicia Zukas United States 9 170 0.6× 153 1.2× 259 2.3× 99 1.0× 92 1.1× 21 687
Wan‐Ting Ho United States 18 524 1.7× 76 0.6× 43 0.4× 51 0.5× 60 0.7× 33 856
Juergen Fingerle Switzerland 11 185 0.6× 52 0.4× 71 0.6× 96 1.0× 48 0.6× 12 611
Svetlana Laidinen Finland 15 288 0.9× 178 1.4× 32 0.3× 52 0.5× 44 0.5× 23 560
Riccardo Chiusaroli United States 17 520 1.7× 244 2.0× 64 0.6× 152 1.6× 115 1.4× 22 898
D Falb United States 6 520 1.7× 158 1.3× 205 1.8× 79 0.8× 155 1.8× 6 1.1k
Harun Elmasri Germany 7 372 1.2× 37 0.3× 46 0.4× 145 1.5× 59 0.7× 7 555

Countries citing papers authored by Kaiming Xu

Since Specialization
Citations

This map shows the geographic impact of Kaiming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaiming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaiming Xu more than expected).

Fields of papers citing papers by Kaiming Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaiming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaiming Xu. The network helps show where Kaiming Xu may publish in the future.

Co-authorship network of co-authors of Kaiming Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Kaiming Xu. A scholar is included among the top collaborators of Kaiming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaiming Xu. Kaiming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koundal, Sunil, Jesús D. Melgarejo, Kaiming Xu, et al.. (2025). Age-dependent brain responses to mechanical stress determine resilience in a chronic lymphatic drainage impairment model. Journal of Clinical Investigation. 135(17). 2 indexed citations
2.
Guo, Qi, Lingyan Ping, Eric B. Dammer, et al.. (2024). Heparin-enriched plasma proteome is significantly altered in Alzheimer’s disease. Molecular Neurodegeneration. 19(1). 67–67. 5 indexed citations
3.
Koundal, Sunil, Xinan Chen, Hedok Lee, et al.. (2024). Divergent brain solute clearance in rat models of cerebral amyloid angiopathy and Alzheimer’s disease. iScience. 27(12). 111463–111463. 2 indexed citations
4.
Yang, Gang, Hua Zhang, Tingmei Chen, et al.. (2016). Metabolic analysis of osteoarthritis subchondral bone based on UPLC/Q-TOF-MS. Analytical and Bioanalytical Chemistry. 408(16). 4275–4286. 42 indexed citations
5.
Wang, Jian, Alton B. Farris, Kaiming Xu, et al.. (2016). GPRC5A suppresses protein synthesis at the endoplasmic reticulum to prevent radiation-induced lung tumorigenesis. Nature Communications. 7(1). 11795–11795. 26 indexed citations
6.
Xu, Kaiming & Hui‐Kuo G. Shu. (2013). Transcription Factor Interactions Mediate EGF-Dependent COX-2 Expression. Molecular Cancer Research. 11(8). 875–886. 21 indexed citations
7.
Shu, Hui‐Kuo G., Younghyoun Yoon, Samuel Hong, et al.. (2013). Inhibition of the CXCL12/CXCR4-Axis as Preventive Therapy for Radiation-Induced Pulmonary Fibrosis. PLoS ONE. 8(11). e79768–e79768. 70 indexed citations
8.
Xu, Kaiming, Lanfang Wang, & Hui‐Kuo G. Shu. (2013). COX-2 overexpression increases malignant potential of human glioma cells through Id1. Oncotarget. 5(5). 1241–1252. 48 indexed citations
9.
Xu, Kaiming, Huiying Gao, & Hui‐Kuo G. Shu. (2011). Celecoxib Can Induce Vascular Endothelial Growth Factor Expression and Tumor Angiogenesis. Molecular Cancer Therapeutics. 10(1). 138–147. 20 indexed citations
10.
Xu, Kaiming, Chad M. Kitchen, Hui‐Kuo G. Shu, & Thomas J. Murphy. (2007). Platelet-derived Growth Factor-induced Stabilization of Cyclooxygenase 2 mRNA in Rat Smooth Muscle Cells Requires the c-Src Family of Protein-tyrosine Kinases. Journal of Biological Chemistry. 282(45). 32699–32709. 25 indexed citations
11.
Peavy, Richard D., Anthony G. Lau, Kaiming Xu, et al.. (2005). Differential Effects of Gqα, G14α, and G15α on Vascular Smooth Muscle Cell Survival and Gene Expression Profiles. Molecular Pharmacology. 67(6). 2102–2114. 13 indexed citations
12.
Murphy, Thomas J., Grace K. Pavlath, Xiaofei Wang, et al.. (2002). Retroviral Vectors Applied to Gene Regulation Studies. Methods in enzymology on CD-ROM/Methods in enzymology. 345. 539–551. 14 indexed citations
13.
Xu, Kaiming, et al.. (2000). Immediate-early MEK-1-dependent Stabilization of Rat Smooth Muscle Cell Cyclooxygenase-2 mRNA by Gαq-coupled Receptor Signaling. Journal of Biological Chemistry. 275(30). 23012–23019. 48 indexed citations
14.
Xu, Kaiming & Thomas J. Murphy. (2000). Reconstitution of Angiotensin Receptor mRNA Down-regulation in Vascular Smooth Muscle. Journal of Biological Chemistry. 275(11). 7604–7611. 23 indexed citations
15.
Xu, Kaiming, et al.. (2000). Cyclosporin A Selectively Inhibits Mitogen-Induced Cyclooxygenase-2 Gene Transcription in Vascular Smooth Muscle Cells. Molecular Pharmacology. 58(4). 701–708. 4 indexed citations
16.
Xu, Kaiming, et al.. (2000). Cyclosporin A Selectively Inhibits Mitogen-Induced Cyclooxygenase-2 Gene Transcription in Vascular Smooth Muscle Cells. Molecular Pharmacology. 58(4). 701–708. 27 indexed citations
18.
Xu, Kaiming, Zhizhen Lü, Hong Wei, Youyi Zhang, & Chide Han. (1998). Alteration of α1-adrenoceptor subtypes in aortas of 12-month-old spontaneously hypertensive rats. European Journal of Pharmacology. 344(1). 31–36. 23 indexed citations
19.
Xu, Kaiming, Fai Tang, & Chide Han. (1997). ALTERATIONS OF mRNA LEVELS OF ai‐ADRENOCEPTOR SUBTYPES WITH MATURATION AND AGEING IN DIFFERENT RAT BLOOD VESSELS. Clinical and Experimental Pharmacology and Physiology. 24(6). 415–417. 13 indexed citations
20.
Zhang, Youyi, Kaiming Xu, & Chide Han. (1997). ALTERATIONS OF CARDIAC α‐ADRENOCEPTOR SUBTYPES IN HYPOTHYROID RATS. Clinical and Experimental Pharmacology and Physiology. 24(7). 481–486. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026